BioSpace News Archive

Commonwealth Diagnostics International, Inc. (CDI) announces its entry into the Canadian healthcare market.

Shorter hospital stays, fewer complications and better patient results are just a few metrics used to rank Mercy as one of the top five large health systems in the nation, alongside Mayo Clinic.

Kraig Biocraft Laboratories, Inc. announces today that it has received approval for the establishment of its new Vietnamese subsidiary, Prodigy Textiles Co. Ltd.

FormFast is pleased to announce long-time customer, War Memorial Hospital, is expanding FormFast to their ambulatory facilities.

Picosun Group reports of groundbreaking results in ALD biobarriers for novel medical applications.

Decision Resources Group (DRG) announced at the AMCP Managed Care and Specialty Pharmacy Annual Meeting the launch of Healthbase.

Vizient announces it is launching the Vizient Achieve Committed ProgramTM.

Caris Life Sciences announced that Piedmont Cancer has joined Caris’ Precision Oncology Alliance™ (POA) as its 22nd member.

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company will host a conference call and live webcast on Thursday, May 3, 2018 at 8:00 A.M. ET to report its first quarter 2018 financial results and to discuss recent business updates.

Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized, sham-controlled, multi-center study of deep brain stimulation (DBS) for advanced, levodopa-responsive Parkinson’s disease (PD) in the United States.